Greater than 95% as determined by SDS-PAGE.
Less than 1.0 EU/ug as determined by LAL method.
Measured by its binding ability in a functional ELISA. Immobilized Human CDCP1 at 2 μg/mL can bind Anti-CDCP1 recombinant antibody (CSB-RA884474MA1HU), the EC50 is 0.2943-0.4429 ng/mL.
Membrane glycoprotein gp140; Subtractive immunization M plus HEp3-associated 135 kDa protein; SIMA135; Transmembrane and associated with src kinases
Homo sapiens (Human)
Target Protein Sequence
Note: We will preferentially ship the format that
we have in stock, however, if you have any special requirement for the format, please remark your
requirement when placing the order, we will prepare according to your demand.
Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature
and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized
form is 12 months at -20°C/-80°C.
3-7 business days
Repeated freezing and thawing is not recommended. Store working aliquots at 4℃ for up to one week.
Datasheet & COA
Please contact us to get it.
The recombinant human CDCP1 protein is synthesized using a mammalian cell expression system. By incorporating the human CDCP1 gene fragment (30-667aa) fused with a C-terminus 10xHis-tag gene into a plasmid vector, the construct is introduced into mammalian cells. Subsequent cell cultivation promotes efficient protein expression. SDS-PAGE analysis confirms the protein's purity surpassing 95%, while the LAL method verifies its low endotoxin levels below 1.0 EU/ug. The protein's functional activity is demonstrated by its interaction with CDCP1 recombinant antibody (CSB-RA884474MA1HU), with the EC50 of 0.2943-0.4429 ng/mL.
CDCP1 is limitedly expressed in normal human tissues but is upregulated in most cancers, including lung cancer, pancreatic cancer, renal cell carcinoma, ovarian cancer, and hepatocellular carcinoma, playing a pivotal role in the onset, progression, and relapse of tumors. The signaling pathways regulated by CDCP1 play a crucial role in promoting cancer and mediating resistance to chemotherapy and targeted therapies. Additionally, its associated antibodies demonstrate high affinity and specificity, making it a potential new target for early cancer treatment. Therefore, the development of CDCP1 protein can contribute to clinical drug development and research related to CDCP1.